Dental hard tissue

Dental hard tissue refers collectively to the three highly mineralized structural components of the tooth: **enamel** (the hard, acellular outer crown layer, composed of ~95% hydroxyapatite by weight), **dentin** (the bulk tissue beneath enamel, containing a collagen-rich organic matrix and mineral phase, harboring microscopic tubules and produced by odontoblasts), and **cementum** (mineralized connective tissue covering the tooth root and anchoring the periodontal ligament)[1][2][5][8][9]. These tissues are critical in the mechanical function, longevity, and sensory perception of teeth but are not themselves molecular targets in the context of drug discovery or receptor/enzyme classification. Key points: - Dental hard tissues are *structural*, not molecular, entities; they lack an associated molecular abbreviation or nomenclature used for drug targets. - Enamel is highly resistant but acellular and cannot self-repair; dentin is less hard but can transmit sensation and has limited regenerative capacity via dental pulp stem cells; cementum anchors the tooth but has limited capacity for remodeling[1][2][8]. - All three tissues’ main clinical concerns involve loss or damage due to caries, mechanical wear, or disease, not drug interaction[2][9]. In summary, "Dental hard tissue" does not correspond to a molecule, receptor, or protein but is an anatomical term for the mineralized tissues of teeth and cannot be used as a therapeutic target according to molecular pharmacology conventions.

Other names

enameldentincementumdental mineralized tissuetooth hard tissue